Description
Mergers and Acquisitions in the IVD Market
Mergers and Acquisitions in the IVD Market records over 220 acquisitions in the in vitro diagnostics (IVD) industry in total, featuring approximately 152 purchase arrangements in 2015-2016 and 69 acquisitions in IVD and related segments so far from 2017 to March 2018.
Among the leading diagnostics companies looking to increase market share and produce revenue growth via acquisition are Abbott/Alere, Beckman Coulter / Danaher, and Roche. Abbott’s acquisition of Alere and related divestures and Danaher’s acquisition of Cepheid are among the specific deals discussed in the report.
The report also details acquisitions driven by the development of cutting-edge technologies such as gene editing, liquid biopsy, microbiome research, and next-generation sequencing.
Gene Editing
Liquid Biopsy
Microbiome
Next-Generation Sequencing
Automation, and the Introduction of New, Large, Automated Platforms
Rapid Point-of-Care Testing with Single Pathogen Infectious Disease Tests
Connectivity
Looking to the East
Table of Contents
1: EXECUTIVE SUMMARY
THE MARKET LANDSCAPE
Roche
Abbott/Alere
Siemens
Beckman Coulter, Inc. / Danaher
The Changing Landscape
MARKET TRENDS HELPING TO DRIVE MERGERS AND ACQUISITIONS
Gene Editing
Liquid Biopsy
Next-Generation Sequencing
Automation, and the Introduction of New, Large, Automated Platforms
Rapid Point-of-Care Testing with Single Pathogen Infectious Disease Tests
Connectivity
Looking to the East
Microbiome
METHODOLOGY
2: IVD MERGERS AND ACQUISITIONS
OVERVIEW: THE IVD INDUSTRY – A CHANGING MARKET
M&A IN SELECTED MARKETS
Lab-Developed Test (LDT) Services Market
The PCR/NAAT Market
Table 2-1: Selected Acquisitions of Diagnostic Companies, from 2017 to mid-March 2018
SELECTED 2017 / 2018 ACQUISITIONS OF NOTE
Abbott: Acquisitions, Divestures and the Alere Deal
Siemens’ Divestiture of a Portion of Its Healthcare Business, Siemens Healthineers
Roche Active in M&A, Part 1
Celgene Active in Early 2018
Agilent Makes Cell Analysis Buy
Charles River Labs Acquires KWS BioTest
Early 2018 M&A Activity in Biotech — Sanofi Buys Bioverativ, Ablynx
Chembio Diagnostics Acquires Malaysian Firm RVR Diagnostics
Konica Minolta Acquires Ambry Genetics
Quidel Amends Alere Deal
Thermo Completes Patheon Acquisition
Agilent Acquires the Molecular and Sample Barcoding Patent Portfolios of Population Genetics
Enterome and Nestle Health Science Form Microbiome Diagnostics Partners
PerkinElmer Expansion via Tulip and Euroimmun Acquisitions
Sysmex Acquires Oxford Gene Technology (OGT)
LabCorp Completes PAML Acquisition
Cathay Fortune International Acquires Molecular Diagnostics Firm Epigenomics
Bio-Rad Acquires ddPCR Developer RainDance
QIAGEN M&A Activity
Agilent Completes the Acquisition of Multiplicom
Grifols Acquires NAT Donor Screening Unit from Hologic
Johnson & Johnson Diabetes Business Attracts Chinese Interest
THE 2015-2016 MARKET
Table 2-2: Selected Acquisitions of Diagnostic Companies, 2015-2016
SELECTED 2015 / 2016 ACQUISITIONS OF NOTE
Roche Active in M&A, Part 2
Danaher’s Acquires Molecular Diagnostics Leader Cepheid for Nearly $4 Billion
Abbott Acquires St. Jude Medical, Adds Patient Monitoring and Neurostimulation Strength
Thermo Fisher Scientific Completes Major Deals in 2016
Beckman Coulter Acquires Siemens Healthcare Diagnostics’ Clinical Microbiology Business
Becton Dickinson (BD) Prepares Its Entrance into Sequencing with Cellular Research Acquisition
Founding CTC Technology Finds Another Home
Curetis Acquires Real-Time qPCR-based Gyronimo Platform from Carpegen GmbH and Systec GmbH . 73
Bruker Acquires Nucleic Acid Testing Assays and Syndromic Panel Technology
LabCorp Completes Its Acquisition of Sequenom
Curetis Acquires Asset from Siemens Technology Accelerator
Debiopharm Group Acquires GenePOC
Luminex Seeks to Leverage Nanosphere’s Verigene Platform
Siemens Expands Its Diagnostics Portfolio
Quest and DiaSorin to Focus on Key Markets Following Acquisition Deal
Immucor Acquires Sirona Genomics
Illumina Establishes GRAIL Bio
Charles River Acquires Agilux, WIL Research, and Oncotest
IBM Healthcare/Watson Continues Expansion
BD Acquires CareFusion
